Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionCallahan Advisors, LLC
Latest Disclosed Ownership13,291 shares
Latest Disclosed Value $ 806,081
Callahan Advisors, LLC reports 6.44% increase in ownership of BRM / Bristol-Myers Squibb Company

On May 12, 2026 - Callahan Advisors, LLC filed a 13F-HR form disclosing ownership of 13,291 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $696,714 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 12,487 shares of Bristol-Myers Squibb Company. This represents a change in shares of 6.44% during the quarter. The current value of the position is $630,392 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Bristol-Myers Squibb COM 110122108 13,291 804 6.44 806 19.76 0.0673
2026-02-06 2025-12-31 13F Bristol-Myers Squibb COM 110122108 12,487 1,407 12.70 674 34.87 0.0554
2025-10-31 2025-09-30 13F Bristol-Myers Squibb COM 110122108 11,080 -411 -3.58 500 -6.03 0.0424
2025-07-28 2025-06-30 13F Bristol-Myers Squibb COM 110122108 11,491 3,095 36.86 532 3.71 0.0478
2025-05-01 2025-03-31 13F Bristol-Myers Squibb COM 110122108 8,396 -177 -2.06 512 5.79 0.0488
2025-01-31 2024-12-31 13F Bristol-Myers Squibb COM 110122108 8,573 1,859 27.69 485 39.48 0.0456
2024-10-30 2024-09-30 13F Bristol-Myers Squibb COM 110122108 6,714 934 16.16 347 44.58 0.0338
2024-07-29 2024-06-30 13F Bristol-Myers Squibb COM 110122108 5,780 1,346 30.36 240 0.00 0.0250
2024-04-24 2024-03-31 13F Bristol-Myers Squibb COM 110122108 4,434 4,434 240 0.0252
2024-01-24 2023-12-31 13F Bristol-Myers Squibb COM 110122108 0 -22,017 -100.00 0 -100.00
2023-10-23 2023-09-30 13F Bristol-Myers Squibb COM 110122108 22,017 -47,818 -68.47 1,278 -71.40 0.1605
2023-07-31 2023-06-30 13F Bristol-Myers Squibb COM 110122108 69,835 -25,034 -26.39 4,466 -32.09 0.5427
2023-04-28 2023-03-31 13F Bristol-Myers Squibb COM 110122108 94,869 -3,912 -3.96 6,575 -7.49 0.8493
2023-02-03 2022-12-31 13F Bristol-Myers Squibb COM 110122108 98,781 2,040 2.11 7,107 3.34 0.9725
2022-11-14 2022-09-30 13F/A-1 Bristol-Myers Squibb COM 110122108 96,741 10,783 12.54 6,877 3.90 0.9876
2022-10-27 2022-09-30 13F Bristol-Myers Squibb COM 110122108 96,741 10,783 6,877 0.9876
2022-07-29 2022-06-30 13F Bristol-Myers Squibb COM 110122108 85,958 3,273 3.96 6,619 9.62 0.8810
2022-04-27 2022-03-31 13F Bristol-Myers Squibb COM 110122108 82,685 4,306 5.49 6,038 23.55 0.6890
2022-02-08 2021-12-31 13F Bristol-Myers Squibb COM 110122108 78,379 -29,813 -27.56 4,887 -23.66 0.5483
2021-11-03 2021-09-30 13F Bristol-Myers Squibb COM 110122108 108,192 4,921 4.77 6,402 -7.23 0.8067
2021-08-11 2021-06-30 13F Bristol-Myers Squibb COM 110122108 103,271 12,575 13.86 6,901 20.52 0.8760
2021-04-21 2021-03-31 13F Bristol-Myers Squibb COM 110122108 90,696 21,696 31.44 5,726 33.79 0.7754
2021-01-20 2020-12-31 13F Bristol-Myers Squibb COM 110122108 69,000 35,858 108.20 4,280 114.21 0.6263
2020-10-26 2020-09-30 13F Bristol-Myers Squibb COM 110122108 33,142 33,142 1,998 0.3267
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.